Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
6.30
-0.03 (-0.47%)
May 19, 2026, 3:00 PM CST

SHA:600223 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8732,8952,9481,7344,3185,139
Cash & Short-Term Investments
2,8732,8952,9481,7344,3185,139
Cash Growth
1.21%-1.79%70.04%-59.85%-15.97%1.27%
Accounts Receivable
544.27509.05511.85599.06428.31306.23
Other Receivables
42.7147.6731.673,0621,3071,226
Receivables
586.97556.72543.523,6611,7401,532
Inventory
452.23437.16558.71525.4446,04748,204
Prepaid Expenses
-00.08-491.91608.15
Other Current Assets
151.4594.0793.4764.023,0323,187
Total Current Assets
4,0643,9834,1445,98455,62958,670
Property, Plant & Equipment
1,1831,1991,1921,2031,3821,345
Long-Term Investments
199.65187.84168.53191.76926.97874.1
Goodwill
153.74153.74153.74153.74155.59160.33
Other Intangible Assets
167.73168.02163.22148.7196.5210.1
Long-Term Deferred Tax Assets
28.7127.6129.8223.66105.04101.25
Long-Term Deferred Charges
85.6684.0491.1153.9652.3440.51
Other Long-Term Assets
48.1754.2658.7358.2626.2213.92
Total Assets
5,9305,8586,0007,81858,47461,415
Accounts Payable
287.49289.39413.35452.989,2668,694
Accrued Expenses
54.62139.48136.53127.321,003948.47
Short-Term Debt
161.01121.05212.12705.222,2703,219
Current Portion of Long-Term Debt
4.991.0112.51790.343,2222,307
Current Portion of Leases
-4.599.218.165.681.99
Current Income Taxes Payable
44.4419.0816.359.5226.5918.81
Current Unearned Revenue
109.23112.01122.97108.4417,86921,686
Other Current Liabilities
220.54159.52183.3199.7816,94414,217
Total Current Liabilities
882.31846.131,1062,40250,60651,093
Long-Term Debt
6644.55665.042,2153,751
Long-Term Leases
3.84.297.5312.9821.377.69
Long-Term Unearned Revenue
51.0851.8151.2355.1855.6359.17
Long-Term Deferred Tax Liabilities
1.821.892.312.738.555.24
Total Liabilities
945.01910.121,2123,13852,90754,916
Common Stock
1,0171,0171,0171,0171,0171,009
Additional Paid-In Capital
614.02614.02612.86612.51617.8616.38
Retained Earnings
2,6342,6022,4752,3852,0822,202
Comprehensive Income & Other
---0.290.33900
Total Common Equity
4,2654,2334,1054,0153,7174,727
Minority Interest
720.58714.95683.47665.371,8501,773
Shareholders' Equity
4,9854,9484,7884,6805,5676,500
Total Liabilities & Equity
5,9305,8586,0007,81858,47461,415
Total Debt
175.8136.94285.922,1827,7359,287
Net Cash (Debt)
2,6972,7582,662-448.16-3,417-4,149
Net Cash Growth
7.65%3.62%----
Net Cash Per Share
2.562.642.62-0.44-3.01-4.01
Filing Date Shares Outstanding
1,0631,0171,0171,0171,0171,009
Total Common Shares Outstanding
1,0631,0171,0171,0171,0171,009
Working Capital
3,1813,1373,0373,5835,0237,577
Book Value Per Share
4.014.164.043.953.663.79
Tangible Book Value
3,9433,9113,7883,7123,3654,357
Tangible Book Value Per Share
3.713.853.733.653.313.43
Buildings
-1,0891,0459171,3121,294
Machinery
-738.73681.06620.81604.52551.66
Construction In Progress
-13.9916.12131.3672.9540.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.